Dick J. Richel

17.6k total citations · 3 hit papers
107 papers, 9.6k citations indexed

About

Dick J. Richel is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dick J. Richel has authored 107 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 30 papers in Molecular Biology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dick J. Richel's work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer Treatment and Pharmacology (14 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). Dick J. Richel is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Cancer Treatment and Pharmacology (14 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). Dick J. Richel collaborates with scholars based in Netherlands, Italy and United States. Dick J. Richel's co-authors include Jan Paul Medema, Louis Vermeulen, Henk‐Jan Guchelaar, Felipe de Sousa e Melo, Maikel P. Peppelenbosch, Giorgio Stassi, Matilde Todaro, Martin R. Sprick, Kristel Kemper and Jurriaan B. Tuynman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Dick J. Richel

107 papers receiving 9.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

2010 1.4k citations Louis Vermeulen, Felipe de Sousa e Melo et al. Nature Cell Biology profile →
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity

2008 597 citations Louis Vermeulen, Matilde Todaro et al. Proceedings of the National Academy of Sciences profile →
Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials

2014 340 citations Dick J. Richel, Mark I. van Berge Henegouwen et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Dick J. Richel

Since Specialization

Citations

This map shows the geographic impact of Dick J. Richel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dick J. Richel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dick J. Richel more than expected).

Fields of papers citing papers by Dick J. Richel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dick J. Richel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dick J. Richel. The network helps show where Dick J. Richel may publish in the future.

Co-authorship network of co-authors of Dick J. Richel

This figure shows the co-authorship network connecting the top 25 collaborators of Dick J. Richel. A scholar is included among the top collaborators of Dick J. Richel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dick J. Richel. Dick J. Richel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer 2021 ·Cancers ·(unknown), (unknown), Oliver J. Gurney‐Champion, Remy Klaassen, (unknown), (unknown), Dick J. Richel, (unknown), Aart J. Nederveen, Hanneke W.M. van Laarhoven, Johanna W. Wilmink	15
2	Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis 2018 ·CardioVascular and Interventional Radiology ·Martijn R. Meijerink, Robbert S. Puijk, Aukje A. J. M. van Tilborg, (unknown), (unknown), Mattias Neyt, (unknown), (unknown), Koert P. de Jong, Dick J. Richel, Warner Prevoo, Joan Vlayen	145
3	Preoperative Chemoradiation Therapy in Combination With Panitumumab for Patients With Resectable Esophageal Cancer: The PACT Study 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Sil Kordes, Mark I. van Berge Henegouwen, Maarten C.C.M. Hulshof, Jacques Bergman, Hans van Vliet, Ellen Kapiteijn, Hanneke W.M. van Laarhoven, Dick J. Richel, Jean H. G. Klinkenbijl, Sybren L. Meijer, Johanna W. Wilmink	23
4	A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer 2012 ·Investigational New Drugs ·Sil Kordes, Dick J. Richel, Heinz‐Josef Klümpen, Mariëtte J. Weterman, (unknown), Johanna W. Wilmink	30
5	Fusion of intestinal epithelial cells with bone marrow derived cells is dispensable for tissue homeostasis 2012 ·Scientific Reports ·Joan H. de Jong, Hans M. Rodermond, Cheryl Zimberlin, (unknown), Felipe de Sousa e Melo, Dick J. Richel, Jan Paul Medema, Louis Vermeulen	15
6	5-aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer 2011 ·Gut ·(unknown), Ashwin A. Dihal, (unknown), Carina L. Bos, Philip W. Voorneveld, Pim J. Koelink, Manon E. Wildenberg, Vanesa Muncan, Jarom Heijmans, Hein W. Verspaget, Dick J. Richel, James C.H. Hardwick, Daniël W. Hommes, Maikel P. Peppelenbosch, Gijs R. van den Brink	27
7	Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation 2011 ·Cancer Letters ·Geerte L. Van Sluis, Lois W. Brüggemann, Charles T. Esmon, Pieter W. Kamphuisen, Dick J. Richel, Harry R. Büller, C. J. F. van Noorden, C. Arnold Spek	16
8	Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies 2011 ·Investigational New Drugs ·Maarten J. Deenen, Heinz‐Josef Klümpen, Dick J. Richel, Rolf W. Sparidans, Mariëtte J. Weterman, Jos H. Beijnen, Jan H.M. Schellens, Johanna W. Wilmink	20
9	Wnt activity defines colon cancer stem cells and is regulated by the microenvironment breakdown → 2010 ·Nature Cell Biology ·Louis Vermeulen, Felipe de Sousa e Melo, Maartje van der Heijden, Kate Cameron, Joan H. de Jong, Tijana Borovski, Jurriaan B. Tuynman, Matilde Todaro, Christian J. Merz, Hans M. Rodermond, Martin R. Sprick, Kristel Kemper, Dick J. Richel, Giorgio Stassi, Jan Paul Medema	1433
10	Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood 2009 ·European Journal of Surgical Oncology ·Jan Wind, Jurriaan B. Tuynman, Arjan G.J. Tibbe, Joost F. Swennenhuis, Dick J. Richel, Mark I. van Berge Henegouwen, Willem A. Bemelman	77
11	Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation 2009 ·Cancer Letters ·Joost J.C. Verhoeff, Lukas J.A. Stalpers, Cornelis J.F. Van Noorden, Dirk Troost, Marja Ramkema, Chris van Bree, Ji‐Ying Song, Mila Donker, Martha Chekenya, W. Peter Vandertop, Dick J. Richel, Wouter R. van Furth	5
12	Understanding Palliative Cancer Chemotherapy: About Shared Decisions and Shared Trajectories 2009 ·Health Care Analysis ·(unknown), Jeannette Pols, Dick J. Richel, (unknown), Dick L. Willems	15
13	Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity breakdown → 2008 ·Proceedings of the National Academy of Sciences ·Louis Vermeulen, Matilde Todaro, (unknown), Martin R. Sprick, Kristel Kemper, (unknown), Dick J. Richel, Giorgio Stassi, Jan Paul Medema	597
14	Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: A review of randomized controlled clinical trials 2006 ·European Journal of Cancer ·(unknown), Pax H.B. Willemse, Jolanda M. Habraken, Hanneke C.J.M. de Haes, Dick L. Willems, Dick J. Richel	25
15	The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Malignancy 2005 ·Journal of Clinical Oncology ·Clara Klerk, Susanne M. Smorenburg, Hans-Martin Otten, Anthonie W.A. Lensing, Martin H. Prins, Franco Piovella, Paolo Prandoni, Monique M.E.M. Bos, Dick J. Richel, Geertjan van Tienhoven, Harry R. Büller	481
16	A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer 2005 ·Annals of Oncology ·D. Rea, J. W. R. Nortier, W.W. ten Bokkel Huinink, Stephen Falk, Dick J. Richel, Tim Maughan, Gerard Groenewegen, Jeff M. Smit, Neil Steven, (unknown), Dorothée Sémiond, Rachel Kerr, Cornelis J.A. Punt	69
17	Coagulation factors VIIa and Xa inhibit apoptosis and anoikis 2004 ·Oncogene ·Henri H. Versteeg, C. Arnold Spek, Dick J. Richel, Maikel P. Peppelenbosch	89
18	Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. 2000 ·Data Archiving and Networked Services (DANS) ·André B. P. Kuilenburg, Janet Haasjes, Dick J. Richel, Lida Zoetekouw, Henk van Lenthe, Ronney A. De Abreu, Jan Gerard Maring, P. Vreken, A. H. van Gennip	307
19	Oligoclonal Peripheral T-Cell Lymphocytosis as a Result of Aberrant T-Cell Development in a Cortical Thymoma 1997 ·Diagnostic Molecular Pathology ·Daphne de Jong, Dick J. Richel, (unknown), Lucie Boerrigter, Laura J. van’t Veer	10
20	Feasibility study of high-dose carboplatin and etoposide in the salvage treatment of testicular cancer 1992 ·Annals of Oncology ·Sjoerd Rodenhuis, L.T. Vlasveld, R. Dubbelman, (unknown), Jan H. Schornagel, J. Wanders, (unknown), E.M. Bais, W W ten Bokkel Huinink, Dick J. Richel	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact